EFPIA - NEWSLETTER

EFPIA Newsletter 18 March 2021

19 Conversations | The EFPIA podcast series

Podcast: Is intellectual property a barrier to access?

Today we're asking Prof. Dr. Walter Van Dyck, Director of Healthcare Management Centre, Vlerick Business School:

"Is intellectual property a barrier to access?".

IP is the key driver of innovation. It has enabled unprecedented collaborations between biopharmaceutical innovators and governments, universities and other research partners to speed up progress on hundreds of potential COVID-19 treatments, diagnostics and vaccines for patients.

From our blog

18 March 2021 Why I am #TeamVaccines (Guest blog)

Dr Paul Robinson from MSD spends 2-3 half days a week vaccinating people against COVID-19, and says the sense of relief...

16 March 2021 IMI Impact: Driving healthcare’s digital future

The Innovative Medicines Initiative is making it easier to share and use health data for research and care

12 March 2021 That's why I am #TeamVaccines

It is together, by being part of this unprecedented vaccination programme, that we can all play a role in reconnecting...

Videos

Accelerating innovation key to ensuring that no one is left behind

This is how innovation works. You foster, incentivise and support a broad research ecosystem so that science can explore a range of avenues and when the breakthroughs come, new treatments follow.

Mission Possible: The Race for a Vaccine

Facing a deadly new virus infecting millions of people, Pfizer’s bold plan to create the first COVID-19 vaccine is launched.

Events

23 MAR 2021

EFPIA – FIFARMA webinar on new procedures and policies for the Certificate of Pharmaceutical... Virtual Event

This Webinar aims to provide a platform for discussion of new policies, procedures and trends in use of CPP/eCPP

Learn more →

26 MAR 2021

Are current investments in medical research focusing on unmet health needs? Virtual event

This EFPIA event will explore the results of pharmaceutical industry investment in research and development.

Learn more →

This week we are supporting #BrainAwarenessWeek

More than 20 Innovative Medicines Initiative projects are helping advance dementia research: Read our blog

What we are reading

Vaccini in Europa: Tensioni, stop e ritardi 18 March 2021 (Rai News)

COVID-19 Vaccine Manufacturing: DCVMN's contribution to the global scale-up 16 March 2021 (Gavi)

Perspectives on Value Frameworks in Alzheimer’s Disease 15 March 2021 (ISPOR)

How competition nearly killed Alzheimer’s research 15 March 2021 (IMI)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶